MedPath

Comparing the prophylaxis effects of Metoprolol and Magnesium on prevention of AFatrial fibrillation after CABG ( coronary artery bypass graft)

Phase 2
Recruiting
Conditions
atrial fibrillation.
Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
Registration Number
IRCT2016031520258N5
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
195
Inclusion Criteria

All patients undergoing non-emergency CABG; all patients in ASA class 3 and 4; all patients during surgery is less than 6 hours; all patients without previous history of arrhythmia and atrial fibrillation ; patients without history the anti-arrhythmia Exclusion criteria: All patients during surgery have more than 6 hours; patients undergoing emergency CABG; patients who are undergoing CABG addition valve replacement surgery; patients with a history of previous arrhythmia and AF had before surgery; patients who have a history of taking drugs arrhythmia; patients who have a history of allergy to Magnesium and Metoprolol

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial fibrillation. Timepoint: in operation and after operation until 3 day. Method of measurement: Electrocardiography.;Pulse of heart. Timepoint: in operation and after operation until 3 day. Method of measurement: count.;Respiratory. Timepoint: in operation and after operation until 3 day. Method of measurement: observation.;Temperature. Timepoint: in operation and after operation until 3 day. Method of measurement: Thermometer.;Blood pressure. Timepoint: in operation and after operation until 3 day. Method of measurement: Barometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath